Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Anteris Technologies Global Corp. (AVR) Financial Statements

Anteris Technologies Global Corp. (AVR) reported trailing twelve-month revenue of $2.2M (down 9.6% year on year) and net income of -$103.6M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$88.2M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AVRAnteris Technologies Global Corp.Follow AVR — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
572.1M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
10 Nov, in 17 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Revenue2.71.92.2
Gross profit1.31.31.7
Research & development51.569.177.2
Operating income-78.4-93.9-106.2
Pre-tax income-76.0-94.2-102.4
Income tax0.00.00.5
Net income-76.3-94.1-103.6
Diluted EPS ($)-3.68-2.55-1.07
Diluted shares (mn)—36.9—

USD millions · SEC XBRL

Anteris Technologies Global Corp. — questions

What is Anteris Technologies Global Corp.'s revenue?
$2.2M over the twelve months to 2026-06-30, down 9.6% year on year, from its 10-Q and 10-K filings.
What is Anteris Technologies Global Corp.'s net income?
-$103.6M over the twelve months to 2026-06-30.
What is Anteris Technologies Global Corp.'s free cash flow?
-$88.2M over the twelve months to 2026-06-30.
What are Anteris Technologies Global Corp.'s diluted earnings per share?
$-1.07 over the twelve months to 2026-06-30.

Every figure on this page comes from Anteris Technologies Global Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.